Human Streptococcus suis Outbreak, Sichuan, China
Hongjie Yu*
1, Huaiqi Jing†
1, Zhihai Chen‡
1, Han Zheng†, Xiaoping Zhu§, Hua Wang¶, Shiwen Wang*, Lunguang Liu§, Rongqiang Zu*, Longze Luo§, Nijuan Xiang*, Honglu Liu§, Xuecheng Liu§, Yuelong Shu*, Shui Shan Lee#, Shuk Kwan Chuang**, Yu Wang*, Jianguo Xu†, Weizhong Yang*

, and the Streptococcus suis study groups
Author affiliations: *Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China; †State Key Laboratory for Infectious Disease Prevention and Control (ICDC), Beijing, China; ‡Beijing Ditan Hospital, Beijing, People's Republic of China; §Sichuan Center for Disease Control and Prevention, Sichuan, People's Republic of China; ¶Jiangsu Center for Disease Control and Prevention, Nanjing, People's Republic of China; #The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; **Centre for Health Protection, Hong Kong Special Administrative Region, People's Republic of China
Main Article
Figure 5

Figure 5.
Ribotyping of Streptococcus suis serotype 2 isolates by PvuII restriction. Lane 1, deceased pig isolate SC5; lane 2, deceased pig isolate SC16; lane 3, patient isolate SC154; lane 4, patient isolate SC160; lane 5, patient isolate SC175; lane 6, patient isolate SC179; lane 7, patient isolate SC204; lane 8, patient isolate SC206; M, molecular size standard.
Main Article
Page created: January 04, 2012
Page updated: January 04, 2012
Page reviewed: January 04, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.